About one year of treatment with Altimmune’s experimental therapy pemvidutide led to reductions in noninvasive markers of liver scarring…
Articles by Marisa Wexler, MS
Throughout 2025, the team at Liver Disease News has reported on the latest research and advances in care related to…
Researchers in the U.S. have developed a rapid point-of-care test that detects active hepatitis C infection by identifying HCV…
About half of children with progressive familial intrahepatic cholestasis (PFIC) were found to have cirrhotic cardiomyopathy (CCM), a form…
The U.S. Food and Drug Administration (FDA) has authorized the use of the first artificial intelligence (AI) drug-development tool for…
Using a minimally invasive method called laparoscopy to conduct standard Kasai surgery significantly reduces blood loss and increases the chances…
Major medical associations and state health departments are moving to maintain the standard of universal hepatitis B vaccination at…
Infection with human cytomegalovirus (HCMV), a common and usually harmless virus, may play a role in the development of…
TAEUS, a diagnostic tool being developed by Endra Life Sciences, measures liver fat levels with similar accuracy to gold-standard…
Nebokitug, an experimental infusion therapy being developed by Chemomab Therapeutics for primary sclerosing…